Hints and tips:
...Smith & Nephew goes up to “overweight” at Morgan Stanley. A V-shaped recovery in kneecaps isn’t in the price, they say....
...Smith & Nephew “lowers growth outlook amid coronavirus uncertainty” and its shares are up more than 8 per cent....
...Of the large-cap health stocks, Vermeer Partners, another London-based wealth manager, favours medical device stocks Zimmer Biomet and Smith & Nephew, given that demand for elective surgery has been deferred...
...Smith & Nephew states that ‘multiple [UK] private hospital groups [are] aiming for late June to restart’ – this is in line with our expectations given that the 14-week NHS deal started 30 March....
...Smith & Nephew’s bought a grommet maker. ... Plague sentiment has shifted to the positive. ... Captain Corelli’s pyrrhic win .......
...Smith & Nephew has withdrawn guidance. Johnson Matthey has closed all its ex-China Clean Air factories and cut profit targets. Gemfields has suspended emerald mining in Zambia and withdrawn guidance....
...Today’s opinion FT View: The dangerous game of Sino-American tit-for-tat A substantive offer from China could head off further escalation Lex: Smith & Nephew: shoot from the hip New chief needs to make...
...Smith & Nephew, the UK medical device maker and perennial M&A target, said its chief executive Olivier Bohuon will retire at the end of next year....
...“When drafting a will, rather than naming one particular child, stating ‘all of my nephews at the date of my death’ could have avoided this.”...
...Is Smith & Nephew the one that got away? The UK medical device maker has long been seen as a potential target for bigger US rivals....
...Smith & Nephew can prosper as a standalone company, its chief executive has insisted, brushing away takeover speculation surrounding the UK medical device maker....
...Smith & Nephew gained 1.3 per cent to £11.63 on the back of an upgrade from Goldman Sachs....
...Smith & Nephew in February agreed to pay $1.7bn for ArthroCare, a Texas-based medical devices company, in a bid to strengthen its position in the US and its presence in sports injury care....
...Smith & Nephew has stepped up its hunt for growth by agreeing to pay $1.7bn for ArthroCare, a Texas-based medical devices company, in a deal that will strengthen the UK group’s position in the US and its...
...Case in point, Smith & Nephew will suspend its share buy-back programme (of which there was admittedly only $74m left to go) to buy Arthrocare for $1.7bn in cash....
...jonathan.guthrie@ft.com Smith & Nephew: kate.burgess@ft.com...
...Artificial joint maker Smith & Nephew has agreed to buy ArthroCare, a Texas-based medical devices company, for $1.7bn in cash to strengthen its sports medicine business....
...Smith & Nephew rose 1.1 per cent to 886p after agreeing to buy ArthroCare, the US developer of cartilage cutting equipment, for $1.5bn or 3.6 times sales....
...There are three narrators: the commandant, the nephew and a member of the Sonderkommando, the Jewish units forced to help with the disposal of gas chamber victims....
...& Nephew and others....
International Edition